Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction

PHASE4CompletedINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2014

Study Completion Date

December 31, 2014

Conditions
Anterior Cruciate Ligament ReconstructionRegional Anesthesia, Saphenous Nerve Block
Interventions
DRUG

Bupivacaine Only

This is the control treatment arm. Patients will receive an ultrasound-guided saphenous nerve block, consisting of 13 ml of 0.5% bupivacaine (a local anesthetic).

DRUG

Bupivacaine with 1 mg of Dexamethasone

This is one of two treatment arms. Patients will receive an ultrasound-guided saphenous nerve block, consisting of 13 ml of 0.5% bupivacaine (a local anesthetic), mixed with 1 mg of dexamethasone. Total injection volume will be 15 ml.

DRUG

Bupivacaine with 4 mg of Dexamethasone

This is one of two treatment arms. Patients will receive an ultrasound-guided saphenous nerve block, consisting of 13 ml of 0.5% bupivacaine (a local anesthetic), mixed with 4 mg of dexamethasone. Total injection volume will be 15 ml.

Trial Locations (1)

10021

Hospital for Special Surgery, New York

All Listed Sponsors
lead

Hospital for Special Surgery, New York

OTHER

NCT01586806 - Comparing Subsartorial Saphenous Nerve Blocks With and Without Dexamethasone for Anterior Cruciate Ligament Reconstruction | Biotech Hunter | Biotech Hunter